INGENERON
InGeneron is a clinical stage cell therapy company. We believe that evidence-based regenerative therapy will redefine the health care experience. Its system is designed to enable doctors to heal patients safely and quickly by unlocking and using the healing potential of their own regenerative cells. Founded in 2006, we are a Houston-headquartered, privately held company that was formed to innovate cell-based technologies for health care and life science research. The work of our scientists and ... doctors in the field of the stem and regenerative cell research has enabled us to develop a regenerative cell therapy product platform for multiple potential applications. This work has yielded numerous peer-reviewed publications and studies on the use of autologous adult stem cells – those that are extracted from and reintroduced into the same person – to promote healing.
INGENERON
Industry:
Alternative Medicine Biotechnology Health Care Therapeutics
Founded:
2006-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.ingeneron.com
Total Employee:
11+
Status:
Active
Contact:
(713)440-9900
Total Funding:
51 M USD
Technology used in webpage:
Wordpress Plugins Euro Cloudflare Network Error Logging ThemePunch WordPress 5.7
Current Advisors List
Current Employees Featured
Founder
Investors List
Sanford Health
Sanford Health investment in Series D - InGeneron
Sanford Health
Sanford Health investment in Series D - InGeneron
Official Site Inspections
http://www.ingeneron.com Semrush global rank: 8.99 M Semrush visits lastest month: 227
- Host name: 104.21.96.1
- IP address: 104.21.96.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "InGeneron"
Leading Regenerative Medicine - Overview - InGeneron
InGeneron is dedicated to developing therapies supported by clinical evidence and approved by the FDA. We are currently enrolling 3 clinical trials and are seeking FDA approval for our cell …See details»
InGeneron - Crunchbase Company Profile & Funding
InGeneron is a clinical stage cell therapy company. We believe that evidence-based regenerative therapy will redefine the health care experience. Its system is designed to enable doctors to heal patients safely and quickly by unlocking …See details»
InGeneron - Wikipedia
InGeneron Inc. is a private multinational medical device and biotechnology company headquartered in Houston, Texas, United States, and with European headquarters in Munich, Germany. InGeneron develops, manufactures, licenses and sells regenerative cell separation and diagnostics tools. InGeneron's technologies enable the preparation of adipose-derived regenerative cells (ADRC) that contain progenitor and stem cells in humans and animals for autologousSee details»
Our Leaders - InGeneron
Previously, he worked at MD Anderson Cancer Center in the department of molecular pathology. Christopher joined InGeneron in 2015 as European director of medical and scientific affairs …See details»
InGeneron - LinkedIn
InGeneron is a clinical-stage biotechnology company developing novel, safe, and evidence-based cell therapies. We are setting new therapeutic standards by enabling minimally invasive treatments ...See details»
InGeneron Company Profile 2024: Valuation, Funding …
InGeneron General Information Description. Developer of regenerative medicine therapies designed to improve healthcare, veterinary, and life science research. The company's therapies are used to prepare adipose-derived regenerative …See details»
InGeneron Company Profile - Office Locations, Competitors ... - Craft
InGeneron has 5 employees across 2 locations and $47.5 m in total funding,. See insights on InGeneron including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Home - InGeneron Clinical Trials
InGeneron is a biotechnology company creating innovative, cell-based technologies for the next generation of medicine. For the past 20 years, we have focused on helping patients impacted by orthopedic conditions. We are …See details»
InGeneron - Funding, Financials, Valuation & Investors - Crunchbase
Organization. InGeneron . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 5. obfuscated. Total Funding …See details»
InGeneron - Contacts, Employees, Board Members, Advisors
Organization. InGeneron . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Contacts 18. About. InGeneron has 2 current employee …See details»
InGeneron - Overview, News & Similar companies | ZoomInfo.com
New Study Reports Broad Applicability of InGeneron’s Regenerative Cell Therapy System Across Patient Groups HOUSTON--(BUSINESS WIRE)--InGeneron, Inc., a clinical stage …See details»
InGeneron - YouTube
InGeneron is a clinical stage cell therapy company. We believe that evidence-based regenerative therapy will redefine the health care experience. Our system is designed to enable doctors to …See details»
InGeneron Publishes Significant Support for the Existence of …
Nov 23, 2021 InGeneron is a clinical-stage biotechnology company developing novel, safe, and evidence-based cell therapies. We are setting new therapeutic standards by enabling …See details»
InGeneron Publishes Overview on Current State and Potential of ...
Jan 24, 2022 InGeneron, Inc. Eckhard Alt, MD, PhD Executive Chairman of InGeneron +1 (713) 440 9900 [email protected] Media Inquiries Jon Stone Stone Communications …See details»
InGeneron Announces Critical In-Depth Analysis of the Results …
InGeneron Announces Critical In-Depth Analysis of the Results from a ...See details»
InGeneron Reports Positive Long-Term Results for its Cell Therapy …
Nov 13, 2023 InGeneron is a clinical-stage biotechnology company developing novel, safe, and evidence-based cell therapies. We are setting new therapeutic standards by enabling …See details»
Pipeline - InGeneron
InGeneron’s Solution. Doctors who treat partial-thickness rotator cuff tear patients in our trial harvest a small sample of adipose tissue under local anesthesia from the patient’s abdominal …See details»
Regeneration Following Autologous Treatment - Latest News
Jan 6, 2022 Explore the latest press releases and important announcements from InGeneron. Home / News. Search for posts. Press Releases Nov 13, 2023. InGeneron Reports Positive …See details»
InGeneron Announces Critical In-Depth Analysis of the Results …
Nov 21, 2023 InGeneron, Inc. Eckhard Alt, MD, PhD Executive Chairman of InGeneron +1 (713) 440 9900 Media Inquiries Marcus DeAyala Corporate Development and Strategy Manager …See details»